Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Integrin alpha 4/CD49d Antibody (Natalizumab), FITC - Chimeric, Novus Biologicals™
SDP

Rabbit Monoclonal Antibody

Supplier:  Novus Biologicals NBP275917F

Catalog No. NBP275917F


Add to Cart

Description

Description

Integrin alpha 4/CD49d Monoclonal specifically detects Integrin alpha 4/CD49d in Human samples. It is validated for Flow Cytometry.
Specifications

Specifications

Integrin alpha 4/CD49d
Monoclonal
FITC
PBS with 0.05% Sodium Azide
ITGA4
The RAMOS cell line, a non-EBV releasing cell line, injected into mice.
0.1 mL
Primary
This antibody binds to the alpha 4 subunit of (alpha)4(beta)1 (also known as very late antigen 4 (VLA-4) or CD49d-CD29) and (alpha)4(beta)7 integrin
Store at 4°C in the dark.
Flow Cytometry
Natalizumab
Flow Cytometry
269C wild type, CD49 antigen-like family member D, CD49d, CD49d antigen, CD49Dantigen CD49D, alpha-4 subunit of VLA-4 receptor, IA4, integrin alpha 4, integrin alpha-4, integrin alpha-4 subunit, Integrin alpha-IV, integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor), MGC90518, very late activation protein 4 receptor, alpha 4 subunit, VLA-4 subunit alpha
Rabbit
Protein A purified
Cancer, Cellular Markers, Cytoskeleton Markers, Phospho Specific
3676.0
Human
IgG κ
Product Suggestions

Product Suggestions

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit